XML 134 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Preferred Stock
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance, preferred stock, shares outstanding (in shares) at Dec. 31, 2022     0        
Beginning balance at Dec. 31, 2022 $ 364,188   $ 0 $ 43 $ 611,739 $ (679) $ (246,915)
Beginning balance, common stock, shares outstanding (in shares) at Dec. 31, 2022       42,832,231      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 14,220       14,220    
Stock option exercises (in shares)       144,043      
Stock option exercises 305       305    
Stock issued - on vested RSAs (in shares)       565,027      
Contingent consideration shares issued (in shares)       116,973      
Contingent consideration shares issued 2,263       2,263    
Settlement of Global Cooling escrow (in shares)       (216,024)      
Settlement of Global Cooling escrow (5,115)       (5,115)    
Foreign currency translation 140         140  
Unrealized gain (loss) on available-for-sale securities 40         40  
Net loss (23,913)           (23,913)
Ending balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2023     0        
Ending balance at Jun. 30, 2023 352,128   $ 0 $ 43 623,412 (499) (270,828)
Ending balance, common stock, shares outstanding (in shares) at Jun. 30, 2023       43,442,250      
Beginning balance, preferred stock, shares outstanding (in shares) at Mar. 31, 2023     0        
Beginning balance at Mar. 31, 2023 358,107   $ 0 $ 43 619,227 (534) (260,629)
Beginning balance, common stock, shares outstanding (in shares) at Mar. 31, 2023       43,289,969      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 6,856       6,856    
Stock option exercises (in shares)       63,105      
Stock option exercises 181       181    
Stock issued - on vested RSAs (in shares)       188,227      
Contingent consideration shares issued (in shares)       116,973      
Contingent consideration shares issued 2,263       2,263    
Settlement of Global Cooling escrow (in shares)       (216,024)      
Settlement of Global Cooling escrow (5,115)       (5,115)    
Foreign currency translation 35         35  
Net loss (10,199)           (10,199)
Ending balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2023     0        
Ending balance at Jun. 30, 2023 352,128   $ 0 $ 43 623,412 (499) (270,828)
Ending balance, common stock, shares outstanding (in shares) at Jun. 30, 2023       43,442,250      
Beginning balance, preferred stock, shares outstanding (in shares) at Dec. 31, 2023   0 0        
Beginning balance at Dec. 31, 2023 $ 337,663   $ 0 $ 45 652,880 (345) (314,917)
Beginning balance, common stock, shares outstanding (in shares) at Dec. 31, 2023 45,167,225     45,167,225      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation $ 14,902       14,902    
Stock option exercises (in shares) 36,250     36,250      
Stock option exercises $ 91       91    
Stock issued – on vested RSUs (in shares)       901,413      
Stock issued – on vested RSUs 1     $ 1      
Common stock shares issued (65)       (65)    
Foreign currency translation (192)         (192)  
Unrealized gain (loss) on available-for-sale securities (18)         (18)  
Net loss (30,940)           (30,940)
Ending balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2024   0 0        
Ending balance at Jun. 30, 2024 $ 321,442   $ 0 $ 46 667,808 (555) (345,857)
Ending balance, common stock, shares outstanding (in shares) at Jun. 30, 2024 46,104,888     46,104,888      
Beginning balance, preferred stock, shares outstanding (in shares) at Mar. 31, 2024     0        
Beginning balance at Mar. 31, 2024 $ 333,405   $ 0 $ 46 659,063 (566) (325,138)
Beginning balance, common stock, shares outstanding (in shares) at Mar. 31, 2024       45,689,583      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 8,719       8,719    
Stock option exercises (in shares)       36,250      
Stock option exercises 91       91    
Stock issued – on vested RSUs (in shares)       379,055      
Common stock shares issued (65)       (65)    
Foreign currency translation 11         11  
Net loss (20,719)           (20,719)
Ending balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2024   0 0        
Ending balance at Jun. 30, 2024 $ 321,442   $ 0 $ 46 $ 667,808 $ (555) $ (345,857)
Ending balance, common stock, shares outstanding (in shares) at Jun. 30, 2024 46,104,888     46,104,888